Funding

DF/HCC offers a variety of funding opportunities to members to encourage and enhance the collaborative spirit of research within the Harvard-affiliated medical community. Annual funding opportunities through DF/HCC have historically included pilot project awards through our Cancer Center development funding budget, SPORE career and project development awards, and jointly sponsored funding opportunities made available through our many partnerships with entities such as the Harvard Catalyst, the U54 DF/HCC UMass Boston Partnership, and the Harvard University Center for AIDs Research.

Two important funding programs have provided substantial opportunities to DF/HCC investigators recently. The Bridge Project, a collaboration between DF/HCC and the Koch Institute for Cancer Research at MIT, offers funding for teams that bring bioengineering, advanced cancer science, and clinical oncology together to address unmet clinical needs and technological solutions. The A. David Mazzone Research Awards Program funds a series of collaborative and innovative cancer research, career development, community outreach, and training projects to address a range of needs in prostate cancer and Lupron-treatable diseases.

Active Funding Opportunities

 

df/hcc Funding opportunity

APPLICATION DEADLINE

DF/HCC Multiple Myeloma SPORE Career Enhancement Award Application due July 15, 2017
DF/HCC Multiple Myeloma SPORE Developmental Research Project  Application due July 15, 2017

  

External Funding Opportunity

Application Deadline

Stand up to Cancer - Lustgarten Foundation Pancreatic Cancer Interception Dream Team LOI Due March 22, 2017, Application due June 26, 2017
Damon Runyon-Rachleff Innovation Award Application due July 6, 2017
Harvard Catalyst Ideation Challenge: Good Questions Meet Big Data Application due July 13, 2017
Mantle Cell Lymphoma Research Initiative LOI Due May 15, 2017, Application due August 1, 2017
Cancer Research Institute Clinic and Laboratory Integration Program (CLIP) Grant Application due November 1, 2017

 

 

NOTABLE NIH OPPORTUNITIES

Application Deadline

Emerging Questions in Cancer Systems Biology (U01) LOI due May 23, 2017 Application due June 23, 2017 
Research Answers to NCI's Provocative Questions (R01) LOI due May 28, 2017 Application due June 28, 2017 
Research Answers to NCI's Provocative Questions (R21)  LOI due May 28, 2017 Application due June 28, 2017
Activities to Promote Technology Research Collaborations (APTRC) for Cancer Research (Admin Supp)  Application due July 25, 2017 
Dissemination and Implementation Research in Health (R01) LOI due September 5, 2017, Application due October 5, 2017
Dissemination and Implementation Research in Health (R21) LOI due September 16, 2017, Application due October 16, 2017
Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) Application due October 5, 2017
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) Application due October 5, 2017
Metabolic Reprogramming to Improve Immunotherapy (R01) Application due October 5, 2017
Gene Fusions in Pediatric Sarcomas (R01) Application due October 5, 2017
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21) Application due October 11, 2017
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01) Application due October 11, 2017
Metabolic Reprogramming to Improve Immunotherapy (R21) Application due October 16, 2017
Gene Fusions in Pediatric Sarcomas (R21) Application due October 16, 2017
 Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer (Admin Supp) Application due November 8, 2017 

Funding Opportunities & Archive